Skip to content

Geron GERN Debt Repayments

Debt Repayments at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$500M
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
$13.66M
Eli Lilly logo
Eli LillyLLY
$750M

Other financials

Income statement

See full
Revenue$51.8M+30.9%
Operating income$158.0K+101%
Net income-$3.6M+81.6%
EPS (diluted)-$0.01+66.7%

Balance sheet

See full
Cash & equivalents$48.7M-12.2%
Total debt$134.0M+10.0%
Total equity$229.1M-14.6%
Total assets$534.1M-5.0%

Cash flow

See full
Operating cash flow-$62.9M-31.1%
CapEx$206.0K+2.0%
Free cash flow-$43.8M-6.8%

Valuation

See full
Market cap$888.51M-8.6%
Enterprise value$973.78M-6.2%
P/S4.7×-174×

Profitability

See full
Operating margin-705.5%-351pp
Net margin-682.5%-339pp
FCF margin-734.4%-365pp

Returns & leverage

See full
Return on equity-27.1%-7.8pp
Debt / equity0.6×+0.1×
Current ratio6.8×-1.1×

Where this comes from

Reported directly by Geron in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermDebt.

The official record: Geron’s 10-K, filed March 2, 2026, on SEC EDGAR. View the filing →

Ask your AI about Geron's debt repayments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Geron's debt repayments?
Geron (GERN) reported debt repayments of $0 in Q4 2025.
How has Geron's debt repayments changed year-over-year?
Geron's debt repayments decreased by 100.0% year-over-year, from $21.64M to $0.
What does debt repayments mean?
Cash used to repay or retire outstanding debt obligations, including scheduled maturities and early redemptions.